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Other names: Adenomatous polyposis of the colon; 
Gardner syndrome 
Inheritance: Autosomal dominant disorder; frequency 
is about 2.5/105 newborns; neomutation in 20%; 
variable expressivity; penetrance close to 100% by the 
age of 40 yrs. 
Clinics 
Phenotype and clinics 
Multiple adenomatous polyps of the colon and the 
rectum. Polyps also develop in the upper 
gastrointestinal tract. Other: pigmented retinal lesions 
(congenital hypertrophy of the retinal pigment 
epithelium), jaw cysts, sebaceous cysts, desmoid 
tumours, and osteomas. 
Neoplastic risk 
Colorectal cancer(s) develop from the polyps through a 
dysplastic stage. Malignancies may be found in other 
sites: liver (hepatoblastoma), brain (medulloblastoma), 
thyroid. 
Prognosis 
Colorectal cancer in early adult life (median age: 40 
yrs) is the first cause of death in this disease. 




Description: Tumour suppressor gene; the APC normal  
 
 
gene product interacts with the adherens junction 
proteins a and b-catenin. 
Mutations 
Germinal: FAP is caused by a highly heterogeneous 
spectrum of point mutations that represents a problem 
for molecular genetic diagnosis; but all the mutations 
are chain terminating and some correlations between 
the position of the mutation and the phenotypic 
consequences have been described: 
- Germline mutations between codons 1250 and 1464 
are associated with profuse polyposis; 
- An attenuated adenomatous polyposis coli (AAPC) is 
associated with mutations located very close to the 5-
prime end of the APC gene; 
- The extent of congenital hypertrophy of the retinal 
pigment epithelium (CHRPE) depends on the position 
of the protein-truncating mutation in APC; CHRPE 
lesions are almost always absent if the mutation occur 
before exon 9, but are consistently present if it occurs 
after this exon; 
- Patients with a mutation between codons 1445 and 
1578 do not express CHRPE; however, these patients 
developed severe desmoid tumours. 
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